Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × Amsacrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 1 Leukemia, Myeloid, Acute 1

Interventions

Dexamethasone 21 Cyclophosphamide 21 Rituximab 16 Cytarabine 16 Methotrexate 11 Gemcitabine 11 fludarabine 10 Filgrastim 10 Bortezomib 10 Lenalidomide 9 Paclitaxel 8 Etoposide 8 pembrolizumab 7 Vincristine 7 Cyclosporine 7 Antilymphocyte Serum 7 pomalidomide 6 fludarabine phosphate 6 carfilzomib 6 Topotecan 6 Temozolomide 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Docetaxel 6 Calcium Dobesilate 6 venetoclax 5 Pemetrexed 5 Mycophenolic Acid 5 Mitoxantrone 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03765541 2025-04-10

DEXAML-03

University Hospital, Toulouse

Phase 3 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡